KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Thermo Fisher Scientific (TMO) over the last 8 years, with Q3 2025 value amounting to $1.6 billion.

  • Thermo Fisher Scientific's Receivables - Other rose 512.65% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 512.65%. This contributed to the annual value of $1.4 billion for FY2024, which is 55.44% down from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Receivables - Other is $1.6 billion, which was up 512.65% from $1.4 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Receivables - Other's 5-year high stood at $1.6 billion during Q3 2025, with a 5-year trough of $783.0 million in Q2 2021.
  • Its 5-year average for Receivables - Other is $1.3 billion, with a median of $1.4 billion in 2023.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 5445.54% in 2022, then tumbled by 393.81% in 2025.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Receivables - Other stood at $968.0 million in 2021, then skyrocketed by 35.54% to $1.3 billion in 2022, then grew by 9.98% to $1.4 billion in 2023, then dropped by 0.55% to $1.4 billion in 2024, then rose by 12.89% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.